Additional file 2: of Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Dong Hyun Oh (2686378)
Jung Ju Kim (4805934)
Jinnam Kim (4805931)
Hye Seong (4805928)
Se Ju Lee (4805925)
Yong Chan Kim (4805937)
Eun Jin Kim (311868)
In Young Jung (2623264)
Woo Yong Jeong (2623273)
Su Jin Jeong (290862)
Nam Su Ku (541740)
Sang Hoon Han (14426)
Jun Yong Choi (290863)
Young Goo Song (290866)
June Myung Kim (290867)

Publication date

January 2018

DOI

10.6084/m9.figshare.5835084.v1

Abstract

Multivariate analysis of prognostic factors for predicting mortality in patients with MSSA bacteremia, with adjustments for prevalence of malignancy, healthcare-associated infections, and CRP. (DOCX 13Â kb

Extracted data

We use cookies to provide a better user experience.

Data Protection

Additional file 2: of Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Dong Hyun Oh (2686378)
Jung Ju Kim (4805934)
Jinnam Kim (4805931)
Hye Seong (4805928)
Se Ju Lee (4805925)
Yong Chan Kim (4805937)
Eun Jin Kim (311868)
In Young Jung (2623264)
Woo Yong Jeong (2623273)
Su Jin Jeong (290862)
Nam Su Ku (541740)
Sang Hoon Han (14426)
Jun Yong Choi (290863)
Young Goo Song (290866)
June Myung Kim (290867)

Open link

Publication date

January 2018

DOI

10.6084/m9.figshare.5835084.v1

Abstract

Extracted data

Jared Greenberg (5144246)
Cara Hrusch (5144252)
Mohammad Jaffery (5144240)
Michael David (35198)
Robert Daum (618022)
Jesse Hall (5144249)
John Kress (5144255)
Anne Sperling (5144243)
Philip Verhoef (5144237)

April 2018

Figure S1. Enrollment. Between July 1, 2013, and October 24, 2014, there were weeks when no patient ...

Additional file 2: of Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality

Jared Greenberg (5144246)
Cara Hrusch (5144252)
Mohammad Jaffery (5144240)
Michael David (35198)
Robert Daum (618022)
Jesse Hall (5144249)
John Kress (5144255)
Anne Sperling (5144243)
Philip Verhoef (5144237)

April 2018

Table S1. Associations between each cytokine level at time point 1 and death during the first 90 day...

Additional file 1: of Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Dong Hyun Oh (2686378)
Jung Ju Kim (4805934)
Jinnam Kim (4805931)
Hye Seong (4805928)
Se Ju Lee (4805925)
Yong Chan Kim (4805937)
Eun Jin Kim (311868)
In Young Jung (2623264)
Woo Yong Jeong (2623273)
Su Jin Jeong (290862)
Nam Su Ku (541740)
Sang Hoon Han (14426)
Jun Yong Choi (290863)
Young Goo Song (290866)
June Myung Kim (290867)

January 2018

Supplement 1. Antibiotic resistance rate of identified Staphylococcus aureus. (DOCX 21Â kb

Additional file 2: of Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis

Changcheng Shi (837948)
Yubo Xiao (5845658)
Qi Zhang (28502)
Qingyu Li (417678)
Fei Wang (19534)
Jing Wu (54032)
Nengming Lin (837949)

October 2018

Forest plots of odds ratios for second outcomes (see in Figure S1-S8). (DOCX 11351 kb

Additional file 1: of Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis

Changcheng Shi (837948)
Yubo Xiao (5845658)
Qi Zhang (28502)
Qingyu Li (417678)
Fei Wang (19534)
Jing Wu (54032)
Nengming Lin (837949)

October 2018

Table S1. Characteristics of the studies included in the meta-analysis. Table S2. Quality of assessm...

Additional file 1: of The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin

Ozlem Equils (254355)
Christopher da Costa (3521204)
Michele Wible (3521207)
Benjamin Lipsky (3490649)

September 2016

Definitions of Clinical and Microbiologic Outcomes. Additional file 1: Table S1. defines the clinica...

Additional file 1. of Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study

Jennifer McDanel (3448559)
Eli Perencevich (676595)
Daniel Diekema (3448565)
Patricia Winokur (2837660)
J. Johnson (3448568)
Loreen Herwaldt (3448562)
Tara Smith (2558311)
Elizabeth Chrischilles (3448571)
Jeffrey Dawson (2147356)
Marin Schweizer (3430745)

December 2015

Susceptibility to antimicrobial agents of MRSA isolates from patients with MRSA pneumonia ( Nâ =â...

Additional file 1: of Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study

Shoshannah Eggers (4963609)
Anna Barker (3448526)
Susan Valentine (4963615)
Timothy Hess (4963618)
Megan Duster (4963612)
Nasia Safdar (361681)

March 2018

ST1. Sensitivity analysis results: frequencies of MRSA, MSSA, and Total SA colonization at the endpo...

Additional file 2: of Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia

Natasha Holmes (4913263)
J. Owen Robinson (4913275)
Sebastiaan van Hal (338431)
Wendy Munckhof (4913278)
Eugene Athan (188019)
Tony Korman (4913266)
Allen Cheng (242877)
John Turnidge (4913272)
Paul Johnson (350591)
Benjamin Howden (4913269)

March 2018

Table S1. Clinical characteristics and risk factors for S. aureus acquisition in cohort. (DOC 49 kb

Additional file 2: Table S1. of Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer

Yoshitaro Shindo (3799696)
Shoichi Hazama (3549395)
Nobuaki Suzuki (191906)
Haruo Iguchi (3799699)
Kazuhiro Uesugi (3799693)
Hiroaki Tanaka (372008)
Atsushi Aruga (3799726)
Takashi Hatori (3799723)
Hidenobu Ishizaki (3799687)
Yuzo Umeda (762721)
Toshiyoshi Fujiwara (157767)
Tetsuya Ikemoto (2666518)
Mitsuo Shimada (529476)
Kazuhiko Yoshimatsu (3799720)
Hiroko Takenouchi (3799711)
Hiroto Matsui (3799714)
Shinsuke Kanekiyo (3799729)
Michihisa Iida (3799690)
Yasunobu Koki (3799702)
Hideki Arima (3799705)
Hiroyuki Furukawa (1612825)
Tomio Ueno (3799717)
Shigefumi Yoshino (3799708)
Tomonobu Fujita (668183)
Yutaka Kawakami (206073)
Yusuke Nakamura (25445)
Masaaki Oka (3799732)
Hiroaki Nagano (282467)

February 2017

Comparison of prognostic factors according to the numbers of peptide-specific responses (n = 36 HLA-...

Additional file 1: of Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study

Leslie Martin (3546686)
Miriam Harris (3546683)
Annie Brooks (771370)
Cheryl Main (771373)
Dominik Mertz (88663)

December 2015

Overview of studies evaluating the impact of antimicrobial stewardship on management and outcomes of...

Additional file 4: of A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections

Qingyi Shi (6637370)
Chen Huang (202847)
Tingting Xiao (838381)
Zhenzhu Wu (2301892)
Yonghong Xiao (248558)

April 2019

Table S1. Risk factors associated with 30âday mortality in patients with CnSPA BSIs. Table S2. Ris...

Additional file 2: of A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections

Qingyi Shi (6637370)
Chen Huang (202847)
Tingting Xiao (838381)
Zhenzhu Wu (2301892)
Yonghong Xiao (248558)

April 2019

Figure S2. Annual incidence of PA bloodstream infections (PA and CnSPA) in hospital and ICU: 2007â...

Additional file 1: of Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia

Natasha Holmes (4913263)
J. Owen Robinson (4913275)
Sebastiaan van Hal (338431)
Wendy Munckhof (4913278)
Eugene Athan (188019)
Tony Korman (4913266)
Allen Cheng (242877)
John Turnidge (4913272)
Paul Johnson (350591)
Benjamin Howden (4913269)

March 2018

Appendix Source of clinical data, clinical covariates collected, study flowchart. (DOCX 174 kb

Additional file 1: of Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality

Jared Greenberg (5144246)
Cara Hrusch (5144252)
Mohammad Jaffery (5144240)
Michael David (35198)
Robert Daum (618022)
Jesse Hall (5144249)
John Kress (5144255)
Anne Sperling (5144243)
Philip Verhoef (5144237)

April 2018

Figure S1. Enrollment. Between July 1, 2013, and October 24, 2014, there were weeks when no patient ...

Additional file 2: of Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality

Jared Greenberg (5144246)
Cara Hrusch (5144252)
Mohammad Jaffery (5144240)
Michael David (35198)
Robert Daum (618022)
Jesse Hall (5144249)
John Kress (5144255)
Anne Sperling (5144243)
Philip Verhoef (5144237)

April 2018

Table S1. Associations between each cytokine level at time point 1 and death during the first 90 day...

Dong Hyun Oh (2686378)
Jung Ju Kim (4805934)
Jinnam Kim (4805931)
Hye Seong (4805928)
Se Ju Lee (4805925)
Yong Chan Kim (4805937)
Eun Jin Kim (311868)
In Young Jung (2623264)
Woo Yong Jeong (2623273)
Su Jin Jeong (290862)
Nam Su Ku (541740)
Sang Hoon Han (14426)
Jun Yong Choi (290863)
Young Goo Song (290866)
June Myung Kim (290867)

January 2018

Supplement 1. Antibiotic resistance rate of identified Staphylococcus aureus. (DOCX 21Â kb

Changcheng Shi (837948)
Yubo Xiao (5845658)
Qi Zhang (28502)
Qingyu Li (417678)
Fei Wang (19534)
Jing Wu (54032)
Nengming Lin (837949)

October 2018

Forest plots of odds ratios for second outcomes (see in Figure S1-S8). (DOCX 11351 kb

Changcheng Shi (837948)
Yubo Xiao (5845658)
Qi Zhang (28502)
Qingyu Li (417678)
Fei Wang (19534)
Jing Wu (54032)
Nengming Lin (837949)

October 2018

Table S1. Characteristics of the studies included in the meta-analysis. Table S2. Quality of assessm...

Ozlem Equils (254355)
Christopher da Costa (3521204)
Michele Wible (3521207)
Benjamin Lipsky (3490649)

September 2016

Definitions of Clinical and Microbiologic Outcomes. Additional file 1: Table S1. defines the clinica...

Additional file 1. of Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study

Jennifer McDanel (3448559)
Eli Perencevich (676595)
Daniel Diekema (3448565)
Patricia Winokur (2837660)
J. Johnson (3448568)
Loreen Herwaldt (3448562)
Tara Smith (2558311)
Elizabeth Chrischilles (3448571)
Jeffrey Dawson (2147356)
Marin Schweizer (3430745)

December 2015

Susceptibility to antimicrobial agents of MRSA isolates from patients with MRSA pneumonia ( Nâ =â...

Additional file 1: of Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study

Shoshannah Eggers (4963609)
Anna Barker (3448526)
Susan Valentine (4963615)
Timothy Hess (4963618)
Megan Duster (4963612)
Nasia Safdar (361681)

March 2018

ST1. Sensitivity analysis results: frequencies of MRSA, MSSA, and Total SA colonization at the endpo...

Additional file 2: of Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia

Natasha Holmes (4913263)
J. Owen Robinson (4913275)
Sebastiaan van Hal (338431)
Wendy Munckhof (4913278)
Eugene Athan (188019)
Tony Korman (4913266)
Allen Cheng (242877)
John Turnidge (4913272)
Paul Johnson (350591)
Benjamin Howden (4913269)

March 2018

Table S1. Clinical characteristics and risk factors for S. aureus acquisition in cohort. (DOC 49 kb

Additional file 2: Table S1. of Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer

Yoshitaro Shindo (3799696)
Shoichi Hazama (3549395)
Nobuaki Suzuki (191906)
Haruo Iguchi (3799699)
Kazuhiro Uesugi (3799693)
Hiroaki Tanaka (372008)
Atsushi Aruga (3799726)
Takashi Hatori (3799723)
Hidenobu Ishizaki (3799687)
Yuzo Umeda (762721)
Toshiyoshi Fujiwara (157767)
Tetsuya Ikemoto (2666518)
Mitsuo Shimada (529476)
Kazuhiko Yoshimatsu (3799720)
Hiroko Takenouchi (3799711)
Hiroto Matsui (3799714)
Shinsuke Kanekiyo (3799729)
Michihisa Iida (3799690)
Yasunobu Koki (3799702)
Hideki Arima (3799705)
Hiroyuki Furukawa (1612825)
Tomio Ueno (3799717)
Shigefumi Yoshino (3799708)
Tomonobu Fujita (668183)
Yutaka Kawakami (206073)
Yusuke Nakamura (25445)
Masaaki Oka (3799732)
Hiroaki Nagano (282467)

February 2017

Comparison of prognostic factors according to the numbers of peptide-specific responses (n = 36 HLA-...

Additional file 1: of Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study

Leslie Martin (3546686)
Miriam Harris (3546683)
Annie Brooks (771370)
Cheryl Main (771373)
Dominik Mertz (88663)

December 2015

Overview of studies evaluating the impact of antimicrobial stewardship on management and outcomes of...

Additional file 4: of A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections

Qingyi Shi (6637370)
Chen Huang (202847)
Tingting Xiao (838381)
Zhenzhu Wu (2301892)
Yonghong Xiao (248558)

April 2019

Table S1. Risk factors associated with 30âday mortality in patients with CnSPA BSIs. Table S2. Ris...

Additional file 2: of A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections

Qingyi Shi (6637370)
Chen Huang (202847)
Tingting Xiao (838381)
Zhenzhu Wu (2301892)
Yonghong Xiao (248558)

April 2019

Figure S2. Annual incidence of PA bloodstream infections (PA and CnSPA) in hospital and ICU: 2007â...

Additional file 1: of Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia

Natasha Holmes (4913263)
J. Owen Robinson (4913275)
Sebastiaan van Hal (338431)
Wendy Munckhof (4913278)
Eugene Athan (188019)
Tony Korman (4913266)
Allen Cheng (242877)
John Turnidge (4913272)
Paul Johnson (350591)
Benjamin Howden (4913269)

March 2018

Appendix Source of clinical data, clinical covariates collected, study flowchart. (DOCX 174 kb

Additional file 1: of Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality

Jared Greenberg (5144246)
Cara Hrusch (5144252)
Mohammad Jaffery (5144240)
Michael David (35198)
Robert Daum (618022)
Jesse Hall (5144249)
John Kress (5144255)
Anne Sperling (5144243)
Philip Verhoef (5144237)

April 2018

Figure S1. Enrollment. Between July 1, 2013, and October 24, 2014, there were weeks when no patient ...

Additional file 2: of Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality

Jared Greenberg (5144246)
Cara Hrusch (5144252)
Mohammad Jaffery (5144240)
Michael David (35198)
Robert Daum (618022)
Jesse Hall (5144249)
John Kress (5144255)
Anne Sperling (5144243)
Philip Verhoef (5144237)

April 2018

Table S1. Associations between each cytokine level at time point 1 and death during the first 90 day...

Additional file 2: of Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Abstract

Extracted data

Additional file 2: of Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Abstract

Extracted data

Related items

Related items